Wittekindt NE, et al. (1995) Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae. DNA Cell Biol 14(4):273-83 PMID:7710684
Wittekindt NE, et al. (1995) Targeting of heterologous membrane proteins into proliferated internal membranes in Saccharomyces cerevisiae. Yeast 11(10):913-28 PMID:8533467
Acuña G, et al. (1994) Reciprocal mitotic recombination is the predominant mechanism for the loss of a heterozygous gene in Saccharomyces cerevisiae. Environ Mol Mutagen 24(4):307-16 PMID:7851343
Ehrenhofer-Murray AE, et al. (1994) The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily. Mol Gen Genet 244(3):287-94 PMID:8058039
Ehrenhofer-Murray AE, et al. (1994) Characterization of the trp5-27 allele used to monitor drug-induced mitotic gene conversion in the Saccharomyces cerevisiae tester strain D7. Mutagenesis 9(4):377-81 PMID:7968581
Sengstag C and Würgler FE (1994) DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes. Mol Carcinog 11(4):227-35 PMID:7999264
Eugster HP, et al. (1992) Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity. Biochem Biophys Res Commun 185(2):641-7 PMID:1610357
Eugster HP, et al. (1990) Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: an alternative enzyme source for in vitro studies. Biochem Biophys Res Commun 172(2):737-44 PMID:2241965
Albertini S, et al. (1988) Induction of mitotic chromosome loss in the diploid yeast Saccharomyces cerevisiae D61.M by genotoxic carcinogens and tumor promoters. Environ Mol Mutagen 11(4):497-508 PMID:3286249